Expansion des précurseurs B polyclonauxDiagnostic différentiel des rechutes de leucémies aiguës lymphoblastiques de l'enfant

Michel Duval(Hôpital Robert-Debré), sous la direction de Georges Flandrin, Nicole Schlegel(Inserm), E Vilmer(Hôpital Robert-Debré), Odile Fenneteau(Assistance Publique – Hôpitaux de Paris), Ghislaine Sterkers(Délégation Paris 7), Hélène Cavé(Hôpital Robert-Debré)

Hématologie

January 20, 1998

Cited by 0

Related Papers

Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3)

|Cell|2003|927

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

|The Lancet|2002|401

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

|Leukemia|2009|338

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

|Blood|2014|327

<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

|Journal of Clinical Oncology|2018|304